This trial compares how two different numbing medications help patients feel the least amount of pain while recovering from surgery.
This will be a prospective randomized controlled trial comparing the outcomes of hernia patients receiving BDE versus Exparel before abdominal wall reconstruction. The study will utilize the pain numeric rating scale (PNRS) validated questionnaire to assess pain levels. Patients will be asked to report their worst pain imaginable.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
128
Bupivacaine, Dexamethasone, Epinephrine for hernia patients receiving abdominal wall reconstruction
Exparel for hernia patients receiving abdominal wall reconstruction
Baylor University Medical Center
Dallas, Texas, United States
Morphine Milligram Equivalent
To evaluate the difference in medication usage/ Morphine Milligram Equivalent (MME) between the two groups
Time frame: Post-Op day 1, 2, 3, 4 and 2 Week Follow-up (Day 14)
Pain control
Compre efficacy in pain control by using the PNRS Questionniare
Time frame: Baseline, Surgery Day, Post-Op day 1, 2, 3, 4 and 2 Week Follow-up (Day 14)
Hospital Stay
To compare the length of hospital, stay between patients receiving BDE and those receiving Exparel.
Time frame: 30-45 days after hospital discharge
Bowel Function
To assess the time to return of bowel function in both groups.
Time frame: 30-45 days after hospital discharge
Total Cost
To compare the total cost between the two groups.
Time frame: 30-45 days after hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.